Julian Hanak

Julian has worked in the biotechnology and biopharmaceutical sector for more than 25 years, holding senior leadership positions in small biotech, CDMO and large pharma companies. Julian was previously at Biogen, where he was SVP and the global Head of Gene Therapy Product and Process Development.

Prior to Biogen, Julian was at Nighstar Therapeutics and Cobra Biologics, where he gained extensive gene therapy drug development, manufacturing and business development experience.

Julian also worked at Astra Zeneca and in research at the National Institute for Medical Research (MRC) and Bioproducts Laboratories. Julian graduated as a Biochemist from University College London and completed his Master’s Degree at Bangor University.